Thomas Kessler

This inventor holds 21 USPTO granted patents and 4 published patent applications, plus 5 CIPO patents and 5 EPO patents, primarily in Pharmaceutical Formulations. Top assignees: Basf Aktiengesellschaft, Abbvie Deutschland Gmbh and Co Kg, Abbvie Inc.. Active years: 1998-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Kessler. Retrieved from https://idiyas.com/inventor/thomas-kessler

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 21 (Patent Applications = 4)

% Patents Active = 66.7

CIPO Patents = 5 (Patent Applications = 2)

EPO Patents = 5 (Patent Applications = 10)

Average Co-Inventor Count = 5.5

ph-index = 5

Forward Citations = 118(Granted Patents)

Company Filing History:

10 out of 10,816

Basf Aktiengesellschaft

patents

4 out of 167

Abbvie Deutschland Gmbh and Co Kg

Basell Polyolefine Gmbh

patents

where one patent can have more than one assignee

Years Active: 1998-2018

Loading Chart...

Areas of Expertise:

Antiviral Dosage Forms

Polymeric Carrier Composition

Monolithic Tablets

Solid Dispersion

Biologically-Active Compounds

Polyethylene Blends

Plant Protection

Enzyme-Containing Granules

Polymeric Extrudates

Vinyl Aromatic Compounds

Active Substances

High Molecular Weight Polymers

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10105365 - Solid antiviral dosage forms (2018-10-23),

2. 9744170 - Solid antiviral dosage forms (2017-08-29),

3. 9414992 - Process for producing a solid dispersion of an active ingredient (2016-08-16),

4. 9402909 - Pharmaceutical dosage form comprising polymeric carrier composition (2016-08-02),

5. 9333204 - Solid antiviral dosage forms (2016-05-10),

6. 9278052 - Method for producing monolithic tablets (2016-03-08),

7. 9205027 - Process for producing a solid dispersion of an active ingredient (2015-12-08),

8. 7294190 - Mixtures of solids, consisting of a reactive sizing agent and starch, method for producing said mixtures and use thereof (2007-11-13),

9. 7078569 - Method for producing alkylketen dimers (2006-07-18),

10. 6632389 - Underwater or under-hydrocarbon pelletizing of biologically-active-compound-containing melts (2003-10-14),

11. 6545093 - High mixture-quality bi-modal polyethylene blends (2003-04-08),

12. 6541425 - Retarding formulations of active substances used for plant protection (2003-04-01),

13. 6475546 - Process for producing enzyme-containing granules (2002-11-05),

14. 6455612 - Apparatus and method for direct injection of additives into a polymer melt stream (2002-09-24),

15. 6423256 - Process for producing solid dosage forms (2002-07-23),

Title: Thomas Kessler: Innovator in Antiviral Therapeutics

Introduction

Thomas Kessler, an esteemed inventor based in Schifferstadt, Germany, is recognized for his significant contributions to the field of antiviral therapeutics. With an impressive portfolio of 21 patents, Kessler has dedicated his career to developing innovative solid dosage forms that enhance the effectiveness of antiviral compounds in treating infections.

Latest Patents

Among Kessler's notable latest patents are his advancements in solid antiviral dosage forms. The present disclosures describe formulations that incorporate antiviral compounds, detailing methods to utilize these forms to effectively treat antiviral infections. His commitment to innovation in this area is evident through the dedicated work he has undertaken in developing these solid dosage forms.

Career Highlights

Kessler has built a robust career, working with leading companies such as BASF Aktiengesellschaft and AbbVie Inc. His experience in these esteemed organizations has played a pivotal role in shaping his approach to pharmaceutical innovations. His extensive knowledge and innovative spirit have allowed him to contribute significantly to advancements in antiviral therapies.

Collaborations

Throughout his career, Kessler has collaborated with accomplished professionals, including Bernd Liepold and Harald Krull. These collaborations have further enhanced the impact of his inventions, facilitating the development of effective antiviral solutions through shared expertise and innovative thinking.

Conclusion

In conclusion, Thomas Kessler stands out as a prolific inventor in the field of antiviral therapeutics. With a strong foundation of 21 patents, his work not only reflects his commitment to innovation but also his unwavering dedication to improving health outcomes. Kessler's contributions continue to influence the landscape of antiviral treatments, demonstrating the vital role that inventive minds play in the advancement of medicine.

Profile summary based on public USPTO records.